Novartis halts kidney transplant drug trial Novartis has announced that trials investigating CFZ533 (iscalimab) in kidney transplant patients has been halted after interim data show it is not as effective as tacrolimus...
Latest articles
Waarom engagement op social media niet de heilige graal is
Waarom engagement op social media niet de heilige graal is Disrupt the data, want algoritmes hebben niet het beste met ons voor Wie iets weet van social media-algoritmes, weet dat ‘engagement’ meestal als heilige graal...
FDA nod for Janssen schizophrenia treatment Invega Hafyera
FDA nod for Janssen schizophrenia treatment Invega Hafyera The phase 3 study results showed that 92% of patients were relapse-free after 12 months The US Food and Drug Administration (FDA) has approved long-acting...
AstraZeneca, European Commission reach agreement over Covid-19 vaccine supply, ending litigation
AstraZeneca, European Commission reach agreement over Covid-19 vaccine supply, ending litigation (pharmabiz.com) AstraZeneca, European Commission reach agreement over Covid-19 vaccine supply, ending litigation...
How Data Informs the Lifecycle of Healthcare Marketing
Healthcare marketing Like everyone else with ad dollars to spend, healthcare marketers are hungry for data. Spurred in part by COVID-19 but still accelerating an ongoing reality, companies have rapidly reallocated...
Embedding Learning in a Learning Health Care System to Improve Clinical Practice
Health care system Problem In an ideal learning health care system (LHS), clinicians learn from what they do and do what they learn, closing the evidence-to-practice gap. In operationalizing an LHS, great strides have...
